(Q34156003)

31 July 2017

1 reference

title

Techniques for blood administration in sickle cell patients (English)

1 reference

31 July 2017

0 references

Eckman JR

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

published in

Seminars in Hematology

1 reference

31 July 2017

volume

38

1 reference

31 July 2017

issue

1 Suppl 1

1 reference

31 July 2017

page(s)

23-29

1 reference

Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Effect of normal cells on viscosity of sickle-cell blood. In vitro studies and report of six years' experience with a prophylactic program of "partial exchange transfusion"

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Broadening the base of a rare donor program by targeting minority populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Symptomatic Crises of Sickle Cell Anemia Treated by Limited Exchange Transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Abnormal rheology of oxygenated blood in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Alloimmunization in two multitransfused patient populations

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Red cell alloimmunization in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

The role of leukodepletion in the control of transfusion-transmitted disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Transfusion medicine. First of two parts--blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Transfusion medicine. Second of two parts--blood conservation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Studies on the destruction of red blood cells. XII. Factors influencing the role of S hemoglobin in the pathologic physiology of sickle cell anemia and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Comparative studies of height and weight as a blood volume reference standard in normal children and children with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Rapid resolution of organic mental syndrome in sickle cell anemia in response to exchange transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Effects of transfusion on rheological properties of blood in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Exchange transfusion in sickle cell disease using a continuous-flow blood cell separator.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Leukocyte Reduction in Blood Component Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Partial exchange transfusion in sickle cell anemia. Use in children with serious complications

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Post-transfusion alloimmunization in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Estimates of need for transfusions during hypertransfusion therapy in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Alloantibody responses in multiply transfused sickle cell patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

The incidence of development of irregular red cell antibodies in patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Effect of deoxygenation on blood rheology in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990057-5

7 January 2021

10.1016/S0037-1963(01)90057-5

Identifiers

DOI

1 reference

31 July 2017

1 reference